Your session is about to expire
← Back to Search
Muscle Stimulation for Stem Cell Transplant Recovery
Study Summary
This trial is testing a new exercise strategy, neuromuscular electrical stimulation, to see if it can help reduce the long-term effects of cancer treatment, including deconditioning, fatigue, and muscle atrophy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has Active NMES been cleared by the FDA?
"Since this is a Phase 2 trial, there is some evidence backing Active NMES's safety but not its efficacy. The team at Power gave it a score of 2."
How many people are being involved in this clinical trial?
"The information on clinicaltrials.gov does show that this trial is still open and looking for 46 participants at 1 site. The posting date was 5/14/2021, with the most recent update being 4/21/2022."
Are researchers still actively recruiting for this trial?
"That's right, the trial is still recruiting patients according to the most recent information on clinicaltrials.gov. The listing was first put up on May 14th, 2021 and edited as recently as April 21st, 2022. They're currently looking for 46 individuals at a single location."
Share this study with friends
Copy Link
Messenger